About
Kelly Chibale
Kelly Chibale is a full Professor of Organic Chemistry at the University of Cape Town (UCT) where he holds the Neville Isdell Chair in African-centric Drug Discovery & Development.
He is also a Schmidt Sciences AI2050 Senior Fellow, Full Member of the UCT Institute of Infectious Disease & Molecular Medicine, the Founder and Director of the UCT Holistic Drug Discovery and Development (H3D) Centre, and Founder and Director of the H3D Foundation NPC.
Kelly obtained his PhD in Synthetic Organic Chemistry from the University of Cambridge in the UK with Stuart Warren. This was followed by postdoctoral stints at the University of Liverpool in the UK with Nick Greeves and at The Scripps Research Institute in the USA with K.C. Nicolaou. He was a Sandler Sabbatical Fellow at the University of California San Francisco, a US Fulbright Senior Research Scholar at the University of Pennsylvania School of Medicine, and a Visiting Professor at Pfizer in the UK.
He serves as Editor-In-Chief (EIC) of the American Chemical Society (ACS) journal ACS Medicinal Chemistry Letters. Kelly’s research interests are in drug discovery and the development of tools and models to contribute to improving treatment outcomes in people of African descent (PAD).
See the world as you want it to be and learn how to make it that way.
More Info
H3D
H3D Foundation
KC Academic